Quick Answer
The key difference is that Mounjaro (tirzepatide) acts on two appetite-regulating hormones, GIP and GLP-1, while Wegovy (semaglutide) acts on GLP-1 alone. Clinical trial data, including the head-to-head SURMOUNT-5 trial, shows Mounjaro produces greater average weight loss. However, both are effective, MHRA-approved treatments and the right choice depends on individual health history, tolerability, and clinical assessment.
Mounjaro and Wegovy are the two leading prescription weight loss injections currently available in the UK, and understanding the difference between them is one of the most useful things you can do before starting treatment. Both are once-weekly injections that reduce appetite by acting on gut hormones, but they work through distinct mechanisms and their clinical outcomes, side effect profiles, and pricing differ in ways that matter to patients. This guide lays out the key differences clearly so you can have a more informed conversation with your prescriber. If you are ready to explore which option suits you best, book an online consultation with Pills2U and explore our weight loss treatment options.
The Core Difference: How Each Medication Works
Wegovy contains semaglutide, a GLP-1 receptor agonist. GLP-1 is a gut hormone released after eating that signals fullness to the brain, slows gastric emptying, and helps regulate blood sugar. Semaglutide mimics this hormone at a sustained level throughout the week.
Mounjaro contains tirzepatide, which activates two receptor types simultaneously: GLP-1 and GIP. GIP is a second gut hormone involved in insulin secretion and fat metabolism. By engaging both pathways, tirzepatide produces a more complex hormonal response than semaglutide alone, which is believed to account for the stronger average weight loss results seen in clinical comparisons.

Mounjaro vs Wegovy: Side by Side
Mounjaro (Tirzepatide)
| Active ingredient | Tirzepatide |
| Mechanism | Dual GIP and GLP-1 agonist |
| Dosing | 2.5mg to 15mg weekly |
| Avg. weight loss | Up to 22.5% at highest dose (SURMOUNT-1) |
| Starting cost | £120 to £180 per month |
| Manufacturer | Eli Lilly |
| UK approval | MHRA approved for weight management |
Wegovy (Semaglutide)
| Active ingredient | Semaglutide |
| Mechanism | GLP-1 receptor agonist only |
| Dosing | 0.25mg to 2.4mg weekly |
| Avg. weight loss | ~15% at full dose (STEP-1) |
| Starting cost | £160 to £200 per month |
| Manufacturer | Novo Nordisk |
| UK approval | MHRA approved for weight management |
Which Produces Greater Weight Loss
Head-to-head data from the SURMOUNT-5 trial comparing tirzepatide directly against semaglutide 2.4mg showed that tirzepatide produced significantly greater average weight loss over 72 weeks. Participants on tirzepatide lost approximately 20.2 percent of body weight compared to 13.7 percent for semaglutide, a difference that was statistically significant. This is consistent with the indirect comparison from each treatment’s own large-scale trials.
For a detailed look at how Wegovy’s side effects compare across treatments, our Wegovy vs Mounjaro comparison covers the clinical differences in more detail. If cost is a deciding factor, our cheapest Wegovy UK guide explains how Wegovy pricing works across the private market.
Side Effect Comparison
| Side Effect | Mounjaro | Wegovy |
|---|---|---|
| Nausea | Very common, particularly during dose escalation | Very common, particularly during dose escalation |
| Diarrhoea | Very common in early treatment | Very common in early treatment |
| Constipation | Common throughout treatment | Common throughout treatment |
| Heart rate increase | Reported in clinical trials | Reported in clinical trials |
| Hair thinning | Uncommon, linked to rapid weight loss | Uncommon, linked to rapid weight loss |
| Gallbladder issues | Associated with rapid weight loss generally | Associated with rapid weight loss generally |
Which Treatment Is Right for You
The right choice depends on your individual health history, existing conditions, how you tolerate each treatment, and your cost considerations. Mounjaro currently shows stronger average weight loss results and has a growing body of evidence. Wegovy has been available for longer and has a more extensive post-market real-world safety dataset.
Neither is universally superior for every individual. Some people respond extremely well to semaglutide while others find tirzepatide produces a meaningfully different and more effective appetite suppression for their physiology. A clinical consultation is the appropriate way to work through the comparison based on your specific circumstances rather than generalisations.
For NHS guidance on weight management treatments broadly, the NHS obesity treatment guidance provides useful clinical context.

Frequently Asked Questions About the Difference Between Mounjaro and Wegovy
Is Mounjaro stronger than Wegovy?
Clinical trial data and head-to-head comparison data suggest that tirzepatide produces greater average weight loss than semaglutide at full therapeutic doses. However, individual responses vary and some people achieve equivalent or better results on Wegovy depending on their physiology.
Can I switch from Wegovy to Mounjaro?
Switching between treatments is clinically possible and is sometimes appropriate when one treatment is not producing sufficient results or is not well tolerated. This should be done under prescriber guidance with appropriate dose adjustment rather than self-initiated.
Are the injections administered the same way?
Both are once-weekly subcutaneous injections into the abdomen, thigh, or upper arm. Both use autoinjector pens, though the pen designs differ between Eli Lilly and Novo Nordisk. The injection process is broadly similar for both.
Which has been available in the UK longer?
Wegovy has been available for weight management in the UK for longer than Mounjaro. This means Wegovy has a larger body of real-world UK prescribing data, while Mounjaro has more recent and larger-scale clinical trial evidence.
Does one cost less than the other overall?
At starting doses, Wegovy tends to be slightly more expensive per month than Mounjaro. At higher doses, Mounjaro can be more expensive. The total cost over a full treatment course depends on which dose each individual settles at and how long they remain on treatment.
Find the Right Treatment for You With Pills2U
Choosing between Mounjaro and Wegovy is a clinical decision best made with proper prescriber input. At Pills2U, our online consultations assess your health history and goals to help identify which treatment is most appropriate for your individual circumstances. Book an online consultation with Pills2U today and explore our weight loss treatment options.


